Skip to Main Content

Paper Details

Comorbidity Influences the Comparative Safety of Biologic Therapy in Older Adults With Inflammatory Bowel Diseases.
Am J Gastroenterol
9
2022
IBD, IBDs, Inflammatory Bowel Diseases, TNF, anti-TNF, inflammatory bowel diseases, patients, tumor necrosis factor, ustekinumab, vedolizumab
Author NameAffiliation
Tianxi CaiHarvard School of Public Health
Tianxi CaiHarvard School of Public Health
Ashwin N AnanthakrishnanMassachusetts General Hospital
  • 1 - 3

Datasets

Release 1.2